Call to arrange a consultation
+1 416 777 0888

Pharmascience Inc v. AstraZeneca Canada Inc.

Represented Pharmascience in an appeal of a case pursuant to the Patented Medicine (Notice of Compliance Regulations) in respect of esomeprazole. Succeeded on appeal in reversion prohibition order prohibiting Pharmascience from obtaining its Notice of Compliance. The decision is reported at 2014 FCA 133.

Meet the team